EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study

Jennifer C Davies, Suzanne Carter, Jiexin Cao, Maya Whittaker, Helena O'Flynn iD, Clare Gilham, Peter Sasieni, Alexandra Sargent, Emma J Crosbie iD

British Journal of General Practice · 2025

DOI: 10.3399/bjgp.2025.0105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of General Practice, 2025. Verfasst von Jennifer C Davies und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, U…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Early Detection of Cancer, Papillomaviridae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical screening uptake is decreasing in the UK, with only 67.5% of those eligible under 50 years old attending in 2022. Barriers include restricted access to screening appointments and poor acceptability of the speculum examination. Urine self-sampling is an alternative cervical screening method that has the potential to improve uptake.

Aim

To determine the clinical performance and acceptability of human papillomavirus (HPV)-tested urine for cervical screening in a UK general screening population. Design and setting Prospective, cross-sectional diagnostic test accuracy study in North-West England.

Method

Urine was self-collected using a first-void urine (FVU) collection device (DNA Genotek Colli-Pee® 10 ml with urine conservation medium) before obtaining matched routine cervical screening samples. HPV testing used Roche Cobas® 8800 at cervical sample thresholds. A questionnaire evaluated urine self-sampling acceptability. HPV-positive cervical samples underwent reflex cytology, managed under standard NHS protocols, and clinical outcomes were collected.

Results

In total, 1517 participants provided matched urine and cervical samples. There were 207 of 1517 (13.6%) cervical and 245 of 1517 (16.2%) urine samples that were HPV positive with a 1.6% ( n = 25/1517) incidence of cervical intraepithelial neoplasia (CIN)2+ following colposcopic assessment ( n = 80). The specificity of urine was non-inferior ( P = 0.0004) to the specificity of cervical samples at 85.19% (95% confidence interval [CI] = 83.28 to 86.95) versus 87.80% (95% CI = 86.03 to 89.42), giving a relative specificity of 0.97 (95% CI = 0.95 to 0.99). Urine detected 24 of 25 (96.0%) participants with CIN2+. In the future, 41.6% ( n = 575/1382) of participants would prefer current cervical screening, compared with 30.0% ( n = 414/1382) with no preference and 28.4% ( n = 393/1382) preferring urine self-sampling.

Conclusion

HPV-tested urine showed non-inferior specificity to cervical samples in a general screening population. Urine self-sampling was acceptable to current attenders but some prefer traditional screening, making choice an important consideration for policymakers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsEarly Detection of CancerPapillomaviridaeMass ScreeningUterine Cervical DysplasiaHumansFemaleCross-Sectional StudiesMiddle AgedProspective StudiesAdultUnited KingdomSensitivity and SpecificityEnglandPatient Acceptance of Health CareSelf CareVaginal SmearsAgedUrine Specimen CollectionHuman Papillomavirus Viruses

Stichwörter der Autor:innen

cervical cancerdiagnostic test accuracyhuman papillomavirus testingscreeningself-samplingurine

Autor:innen und Institutionen

  • Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Department of Obstetrics and Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Bowland Medical Practice, Manchester, UK.
  • Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Cervical Screening Laboratory, Clinical Sciences Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

ORCID-Profile: Helena O'Flynn, Emma J Crosbie

Zitieren

APA

Davies, J. C., Carter, S., Cao, J., Whittaker, M., O'Flynn, H., Gilham, C., Sasieni, P., Sargent, A., & Crosbie, E. J. (2025). Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study. British Journal of General Practice. https://doi.org/10.3399/bjgp.2025.0105

Vancouver

Davies JC, Carter S, Cao J, Whittaker M, O'Flynn H, Gilham C, et al. Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study. British Journal of General Practice. 2025. doi:10.3399/bjgp.2025.0105

BibTeX
@article{Davies2025,
  author = {Davies, Jennifer C and Carter, Suzanne and Cao, Jiexin and Whittaker, Maya and O'Flynn, Helena and Gilham, Clare and Sasieni, Peter and Sargent, Alexandra and Crosbie, Emma J},
  title = {Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study},
  journal = {British Journal of General Practice},
  year = {2025},
  doi = {10.3399/bjgp.2025.0105}
}
Kostenlos starten →